Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: The Scientific Basis of Rheumatology

Review

Perspectives for TNF-α-targeting therapies

Hanns-Martin Lorenz* and Joachim R Kalden

Arthritis Res 2002, 4(Suppl 3):S17-S24 doi:10.1186/ar564


London, UK. 24-26 June 2002

No comments have yet been made on this article.

Post a comment